А. А. Шутылев

ORCID: 0000-0003-2859-4229
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Multiple Myeloma Research and Treatments
  • Hemophilia Treatment and Research
  • Synthesis of Tetrazole Derivatives
  • Peptidase Inhibition and Analysis
  • Chronic Lymphocytic Leukemia Research
  • Cancer Treatment and Pharmacology
  • Erythropoietin and Anemia Treatment
  • Platelet Disorders and Treatments
  • Hemostasis and retained surgical items
  • Chronic Myeloid Leukemia Treatments

Perm State University
2024

Perm Regional Oncology Center
2020-2022

St. Petersburg State Medical Academy "City Polyclinic №44"
2018

Introduction. Given the possibility of preserving molecular remission in 40–60 % patients with chronic myeloid leukemia (CML) a stable deep response (MR) after discontinuation tyrosine kinase inhibitors (TKI), it is important to determine number candidates for observation treatment-free (TFR) and terms treatment cancellation. Aim — evaluate probability MR rate who meet criteria TFR Russian part international multicenter prospective population study EUTOS PBS (European Treatment Outcome Study...

10.35754/0234-5730-2022-67-3-351-366 article EN Russian journal of hematology and transfusiology 2022-10-22

Background . The treatment options for patients with multiple myeloma who refractory to previous bortezomib and lenalidomide therapy are limited. Pomalidomide is ап immunomodulatory agent that was registered the of double myeloma. Aim To evaluate efficacy, safety optimal course pomalidomide in routine practice Materials methods Overall, 71 were included retrospective analysis. There 36 males 35 females. median age 61 years (range 35-79). According Durie-Salmon staging system, there 53 (79.1...

10.17650/1818-8346-2022-17-3-48-61 article EN cc-by Oncohematology 2022-07-20

The article presents a brief review of the literature on current understanding etiology, pathogenesis, clinic, diagnosis and treatment acquired form hemophilia, as well clinical case this pathology with successful treatment.

10.18821/0023-2149-2018-96-4-361-364 article EN Clinical Medicine (Russian Journal) 2018-09-26

The aim of the work is to describe clinical case formation, diagnosis and treatment acquired form blood clotting factor VIII deficiency – hemophilia A. Material methods . Patient R., 71 years, from April 2018, was found an acute hemorrhagic syndrome in hematomic type large hematomas manifested submandibular region, neck, chest, right breast, pubic inguinal regions on right, anterior-medial surface left femur, anterior tibia. Standard laboratory tests, computed tomography soft tissues lungs,...

10.17650/1818-8338-2019-13-3-4-74-77 article EN cc-by The Clinician 2020-01-30
Coming Soon ...